URN:NBN:SI:doc-K0TJLOQE2005Mavri, Alenkadocuments/doc/K/URN_NBN_SI_doc-K0TJLOQE_001.htmdocuments/doc/K/URN_NBN_SI_doc-K0TJLOQE_001.pdfdocuments/doc/K/URN_NBN_SI_doc-K0TJLOQE_001.txt674articlestr. 375-3791318-034719576537URN:NBN:SI:doc-K0TJLOQEslvSlovensko zdravniško društvoZdravniški vestnikBY-NCaterosklerozaAtherosclerosisDebelostDiabetes Mellitus, Non-Insulin-DependentHiperinzulinemijaHiperlipidemijaHipertenzijaHyperinsulinemiaHyperlipidemiaHypertensioninsulinInsulin ResistanceInsulinska rezistencametabolizemObesityPlasminogen Activator Inhibitor 1Plazminogen aktivator, inhibitor 1presnovne motnjeSladkorna bolezen, ne-inzulin-odvisnaMetabolic syndrome, plasminogen activator inhibitor (PAI-1) and atherosclerosisPovezava med metabolnim sindromom, inhibitorjem aktivatorja plazminogena (PAI-1) in aterosklerozo